Bacil Pharma Ltd Stock Analysis

BSE: 524516 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 09-Dec-2022 12:33
7.39 -0.38 (-4.89%)

DeciZen - Make an Informed Decision on Bacil Pharma

M-Cap below 100cr DeciZen not available

Bacil Pharma Price Chart

P/E Ratio (SA) :
0.00
Market Cap :
4.6 Cr.
52-wk low :
3.7
52-wk high :
9.6
Bole Toh?

1. Is Bacil Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bacil Pharma Ltd is a below average quality company.

2. Is Bacil Pharma Ltd undervalued or overvalued?

The key valuation ratios of Bacil Pharma Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Bacil Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bacil Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bacil Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bacil Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % -0.1%-0.9%-0.5%-1%-1.1%-29.3%-10.9%-7.1%-8.7%-87%-
Value Creation Index -1.0-1.1-1.0-1.1-1.1-3.1-1.8-1.5-1.6-7.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1.10000000000
YoY Gr. Rt. %--100%NANANANANANANANA-
Adj EPS -0-0.1-0.1-0.1-0.1-2.3-0.4-0.2-0.2-2.1-6.4
YoY Gr. Rt. %-NANANANANANANANANA-
BVPS (₹) 10.1109.98.69.82.72.21.31.311
Adj Net Profit 0-0.10-0.1-0.1-1.3-0.2-0.1-0.1-1.2-4
Cash Flow from Ops. 0.1-0.10.30.101.4-0.3-0.4-0.4-4-
Debt/CF from Ops. 0-1.60.64.5-66.60-0.3-0.5-0.4-0-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%NANANA
Adj EPS NANANANA
BVPS -22.7-36.7-22.6-21.9
Share Price 8.6% 3.7% 57.3% 78.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % -0.1-0.9-0.5-1-1.2-30.8-11.1-8.1-10.1-94-625.6
Op. Profit Mgn % -0.30000000000
Net Profit Mgn % -0.40000000000
Debt to Equity 0000.10.100.10.10.100
Working Cap Days 2790000000000
Cash Conv. Cycle 1000000000000

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Bacil Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) -6.4 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 1 -
Reserves (₹ Cr.) -5 -
P/BV 7.57 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 3.67 / 9.55
All Time Low / High (₹) 0.80 / 25.00
Market Cap (₹ Cr.) 4.6
Equity (₹ Cr.) 5.9
Face Value (₹) 10
Industry PE 37

Management X-Ray of Bacil Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bacil Pharma

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Bacil Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bacil Pharma on 09-Dec-2022 12:33 is : 7.39.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Dec-2022 12:33 the market cap of Bacil Pharma stood at ₹ 4.58.
The latest PE ratio of Bacil Pharma as of 09-Dec-2022 12:33 is 0.00.
The latest PB ratio of Bacil Pharma as of 09-Dec-2022 12:33 is 7.57
The 52-week high of Bacil Pharma is ₹ 9.55 and the 52-week low is ₹ 3.67.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Bacil Pharma is ₹ 0.00 ( Cr.) .

About Bacil Pharma Ltd

Bacil Pharma was incorporated in the year 1987. Its plant is located at Lote-Parshuraram, an industrial area about 250 kilometer from Mumbai city.

Business profile:

The company manufactures bulk pharmaceutical/ chemical manufacturing heavy, medium and fine chemicals. The Lote-Parshuraram plant also has manufacture facility for herbal extract and drug intermediates.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now